LANA KAISER, M.D.; THOMAS J. KELLY, B.S.; MARIA J. PATTERSON, Ph.D.; TOM V. SANCHEZ, B.S.; RONALD S. SHAPIRO, M.D.; GILBERT H. MAYOR, M.D.
Urinary hepatitis B surface antigen (HBsAg) has been shown by radioimmunoassay in 19 of 36 persistent serum HBsAg carriers on maintenance hemodialysis (1); however, data on antigenuria in transplant recipients are less conclusive. Blainey and associates (2) detected low levels of urinary antigen by complement fixation in each of seven transplant recipients without reference to renal function or prior bilateral nephrectomy, therefore, not excluding the in-situ end-stage kidneys as the source of antigenuria. The only previous report of antigenuria measured by radioimmunoassay in a transplant patient with prior bilateral nephrectomy links an adequately functioning allograft to intermittent passage of urinary
KAISER L, KELLY TJ, PATTERSON MJ, SANCHEZ TV, SHAPIRO RS, MAYOR GH. Hepatitis B Surface Antigen in Urine of Renal Transplant Recipients. Ann Intern Med. 1981;94:783–784. doi: 10.7326/0003-4819-94-6-783
Download citation file:
Published: Ann Intern Med. 1981;94(6):783-784.
Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use